Correlation Between Autolus Therapeutics and Equillium
Can any of the company-specific risk be diversified away by investing in both Autolus Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Autolus Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Autolus Therapeutics and Equillium, you can compare the effects of market volatilities on Autolus Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Autolus Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Autolus Therapeutics and Equillium.
Diversification Opportunities for Autolus Therapeutics and Equillium
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Autolus and Equillium is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Autolus Therapeutics and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Autolus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Autolus Therapeutics are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Autolus Therapeutics i.e., Autolus Therapeutics and Equillium go up and down completely randomly.
Pair Corralation between Autolus Therapeutics and Equillium
Given the investment horizon of 90 days Autolus Therapeutics is expected to under-perform the Equillium. But the stock apears to be less risky and, when comparing its historical volatility, Autolus Therapeutics is 1.67 times less risky than Equillium. The stock trades about -0.25 of its potential returns per unit of risk. The Equillium is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 75.00 in Equillium on September 12, 2024 and sell it today you would lose (5.00) from holding Equillium or give up 6.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.45% |
| Values | Daily Returns |
Autolus Therapeutics vs. Equillium
Performance |
| Timeline |
| Autolus Therapeutics |
| Equillium |
Autolus Therapeutics and Equillium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Autolus Therapeutics and Equillium
The main advantage of trading using opposite Autolus Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Autolus Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.| Autolus Therapeutics vs. Equillium | Autolus Therapeutics vs. DiaMedica Therapeutics | Autolus Therapeutics vs. Valneva SE ADR | Autolus Therapeutics vs. Vivani Medical |
| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |